Capricor Therapeutics (United States)
San Diego, CA, United States
Overview
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, Deramiocel, an allogeneic cardiac-derived cell therapy that is currently in late-stage development for the treatment of Duchenne muscular dys
Company network
Hover or focus a node to highlight its relationships. Select a line to see what connects two objects.
Related companies share an industry or country with this company.
View relationships as a table
| From | To | What connects them |
|---|---|---|
| Capricor Therapeutics (United States) | United States | IC360 lists Capricor Therapeutics (United States) in United States. |
| 2 Towns Ciderhouse | United States | IC360 lists 2 Towns Ciderhouse in United States. |
| 4FRNT | United States | IC360 lists 4FRNT in United States. |
| A-dec | United States | IC360 lists A-dec in United States. |
| AAR Corp | United States | IC360 lists AAR Corp in United States. |
| Abbott | United States | IC360 lists Abbott in United States. |
